Valuation : Amedica Corporation

Market Cap 12M 10.34M 9.79M 8.87M 16.64M 1.15B 16.73M 116M 44.7M 583M 45.05M 44.06M 1.84B P/E 2026 *
-0.98x
P/E 2027 * -1.39x
Enterprise Value 12M 10.34M 9.79M 8.87M 16.64M 1.15B 16.73M 116M 44.7M 583M 45.05M 44.06M 1.84B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 2.26x
Free-Float
77.28%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 12M
+2.06%-9.10%-28.12%-6.52% 106B
-1.66%-5.22%-28.22%-5.26% 11.47B
-1.84%-5.76%+102.09%+117.75% 9.86B
-1.34%-6.25%-55.03%-72.15% 3.94B
-2.84%-6.11%-30.21%+24.24% 2.33B
+7.16%+15.73%-8.81%-66.74% 2.11B
+1.47%-5.12% - - 1.84B
-2.10%-4.52%-23.51%-30.79% 1.5B
Average -0.78%-3.01%-10.26%-5.64% 17.34B
Weighted average by Cap. +1.32%-7.89%-19.21%-0.02%

Financials

2026 *2027 *
Net sales 2.96M 2.55M 2.41M 2.19M 4.1M 282M 4.12M 28.63M 11.01M 144M 11.1M 10.85M 454M 5.3M 4.57M 4.32M 3.92M 7.35M 506M 7.39M 51.36M 19.75M 258M 19.91M 19.47M 814M
Net income -12.39M -10.67M -10.11M -9.16M -17.19M -1.18B -17.27M -120M -46.16M -602M -46.52M -45.5M -1.9B -11.3M -9.74M -9.22M -8.36M -15.68M -1.08B -15.76M -109M -42.11M -549M -42.44M -41.51M -1.74B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!